Comprehensive NGS tumor profiling panel for all solid tumors
NGS tumor profiling panel for non-small cell lung cancer
NGS tumor profiling panel for colorectal cancer
PD-L1/PD-1,and MMR for solid tumors
Mutational landscape of cfDNA identifies distinct molecular features associated with therapeutic response to first-line platinum based doublet chemotherapy in patients with advanced NSCLC. Theranostics. 2017; 7(19): 4753-4762
Noninvasive identification of hepatocellular carcinoma mutations in plasma circulating cell-free DNA by targeted deep sequencing.